Estelamari Rodríguez
@latinamd.bsky.social
Associate Director Community Outreach- DEI- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed
In just 2 days, join us during #ASCO25 for a special session on "Leveraging Social Media for Your Career" with @marklewismd
▶️ Finding your voice (among all the noise)
▶️ Expand your network
▶️ Promote your research
📆 Friday, May 30th
⏰ 3:00-3:45PM
📍Hall C, ASCO Trainee Lounge
@ASCOTECAG
▶️ Finding your voice (among all the noise)
▶️ Expand your network
▶️ Promote your research
📆 Friday, May 30th
⏰ 3:00-3:45PM
📍Hall C, ASCO Trainee Lounge
@ASCOTECAG
May 29, 2025 at 4:09 AM
In just 2 days, join us during #ASCO25 for a special session on "Leveraging Social Media for Your Career" with @marklewismd
▶️ Finding your voice (among all the noise)
▶️ Expand your network
▶️ Promote your research
📆 Friday, May 30th
⏰ 3:00-3:45PM
📍Hall C, ASCO Trainee Lounge
@ASCOTECAG
▶️ Finding your voice (among all the noise)
▶️ Expand your network
▶️ Promote your research
📆 Friday, May 30th
⏰ 3:00-3:45PM
📍Hall C, ASCO Trainee Lounge
@ASCOTECAG
So many abstracts so little time⌚!
Here are #ASCO25 Top Lung Cancer Abstract Presentations to watch for -Part 1
Not a lot of new drugs but important updates on #perioperative and #targetedtherapy trials. Full abstracts available 5/22.
#lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
Here are #ASCO25 Top Lung Cancer Abstract Presentations to watch for -Part 1
Not a lot of new drugs but important updates on #perioperative and #targetedtherapy trials. Full abstracts available 5/22.
#lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
May 15, 2025 at 10:30 AM
So many abstracts so little time⌚!
Here are #ASCO25 Top Lung Cancer Abstract Presentations to watch for -Part 1
Not a lot of new drugs but important updates on #perioperative and #targetedtherapy trials. Full abstracts available 5/22.
#lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
Here are #ASCO25 Top Lung Cancer Abstract Presentations to watch for -Part 1
Not a lot of new drugs but important updates on #perioperative and #targetedtherapy trials. Full abstracts available 5/22.
#lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
#ASCO25 Top Lung Cancer Abstract Presentations to watch for Trainees (a working list)
Updates on #perioperative and #targetedtherapy trials.
#CM77T #CM816, #NEOADAURA, #ALNEO, #SACHI, #KRYSTAL-2 #lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
Updates on #perioperative and #targetedtherapy trials.
#CM77T #CM816, #NEOADAURA, #ALNEO, #SACHI, #KRYSTAL-2 #lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
May 13, 2025 at 8:17 AM
#ASCO25 Top Lung Cancer Abstract Presentations to watch for Trainees (a working list)
Updates on #perioperative and #targetedtherapy trials.
#CM77T #CM816, #NEOADAURA, #ALNEO, #SACHI, #KRYSTAL-2 #lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
Updates on #perioperative and #targetedtherapy trials.
#CM77T #CM816, #NEOADAURA, #ALNEO, #SACHI, #KRYSTAL-2 #lcsm
@hemoncfellows @hemoncmiami @sylvestercancer
#ASCOAdvocacySummit Walked 14,000 steps today to visit the offices of 2 senators & 4 Representatives in Congress with the awesome delegation of oncologists from FL to advocate for #NIHFunding #cancerresearch #priorauthorization
#drugshortages
#physicianadvocates @ascocancer @sylvestercancer
#drugshortages
#physicianadvocates @ascocancer @sylvestercancer
April 9, 2025 at 2:47 AM
#ASCOAdvocacySummit Walked 14,000 steps today to visit the offices of 2 senators & 4 Representatives in Congress with the awesome delegation of oncologists from FL to advocate for #NIHFunding #cancerresearch #priorauthorization
#drugshortages
#physicianadvocates @ascocancer @sylvestercancer
#drugshortages
#physicianadvocates @ascocancer @sylvestercancer
Thank you @RepMoskowitz for meeting with us to discuss funding for #CancerResearch, #PriorAuthorization reform and #DrugShortages #AscoAdvocacySummit @SylvesterCancer @ASCO
#ASCOAdvocacy
#ASCOAdvocacy
April 8, 2025 at 5:53 PM
Thank you @RepMoskowitz for meeting with us to discuss funding for #CancerResearch, #PriorAuthorization reform and #DrugShortages #AscoAdvocacySummit @SylvesterCancer @ASCO
#ASCOAdvocacy
#ASCOAdvocacy
Florida @ASCO Delegation at Capitol Hill this morning for #ASCOAdvocacySummit @RManochakian @atperez_md @DevikaDasMD @Sonampuri
April 8, 2025 at 2:45 PM
Florida @ASCO Delegation at Capitol Hill this morning for #ASCOAdvocacySummit @RManochakian @atperez_md @DevikaDasMD @Sonampuri
Thank you, @ASCO
for naming me an Advocacy Champion at the #ASCOAdvocacySummit. I am proud to advocate on issues important to our patients like
#PriorAuth
#CancerResearch #NIHFunding
#DrugShortages
Looking forward to impactful conversations at Capitol Hill tomorrow!
@SylvesterCancer
for naming me an Advocacy Champion at the #ASCOAdvocacySummit. I am proud to advocate on issues important to our patients like
#PriorAuth
#CancerResearch #NIHFunding
#DrugShortages
Looking forward to impactful conversations at Capitol Hill tomorrow!
@SylvesterCancer
April 7, 2025 at 5:21 PM
Thank you, @ASCO
for naming me an Advocacy Champion at the #ASCOAdvocacySummit. I am proud to advocate on issues important to our patients like
#PriorAuth
#CancerResearch #NIHFunding
#DrugShortages
Looking forward to impactful conversations at Capitol Hill tomorrow!
@SylvesterCancer
for naming me an Advocacy Champion at the #ASCOAdvocacySummit. I am proud to advocate on issues important to our patients like
#PriorAuth
#CancerResearch #NIHFunding
#DrugShortages
Looking forward to impactful conversations at Capitol Hill tomorrow!
@SylvesterCancer
#ASCOAdvocacySummit learning from @ASCO experts on the hurdles and process to get #PriorAuthorizationBill created and why it takes yrs to get things done. Our cancer pts can’t afford delays #FixPriorAuthorization
April 7, 2025 at 3:24 PM
#ASCOAdvocacySummit learning from @ASCO experts on the hurdles and process to get #PriorAuthorizationBill created and why it takes yrs to get things done. Our cancer pts can’t afford delays #FixPriorAuthorization
#ASCOSAdvocacySummit Capitol Hill Legislative Trainning this morning.
Florida delegation ready to speak to legislators about @ASCO bipartisan priorities:
✅NIH Cancer Research
✅Prior Authorization Bill
✅Cancer Drug Shortages
#physicianadvocates #beatthetable
Florida delegation ready to speak to legislators about @ASCO bipartisan priorities:
✅NIH Cancer Research
✅Prior Authorization Bill
✅Cancer Drug Shortages
#physicianadvocates #beatthetable
April 7, 2025 at 2:29 PM
#ASCOSAdvocacySummit Capitol Hill Legislative Trainning this morning.
Florida delegation ready to speak to legislators about @ASCO bipartisan priorities:
✅NIH Cancer Research
✅Prior Authorization Bill
✅Cancer Drug Shortages
#physicianadvocates #beatthetable
Florida delegation ready to speak to legislators about @ASCO bipartisan priorities:
✅NIH Cancer Research
✅Prior Authorization Bill
✅Cancer Drug Shortages
#physicianadvocates #beatthetable
#ASCOAdvocacySummit starting today with remarks by @RepHerbConaway MD. Honored to be here representing FL oncologists to advocate for issues that impact our patients and field. #patientadvocacy @ascocancer.bsky.social @sylvestercancer
April 7, 2025 at 12:39 AM
#ASCOAdvocacySummit starting today with remarks by @RepHerbConaway MD. Honored to be here representing FL oncologists to advocate for issues that impact our patients and field. #patientadvocacy @ascocancer.bsky.social @sylvestercancer
Best #HappyDoctorsDay 🎉gift celebrating 4 years NED scans after ChemoIO induction and pneumonectomy for locally advanced lung cancer with my patient @SylvesterCancer
👉🏽see patient story in Spanish here: youtu.be/N7SZ2iNfP8g #lcsm
👉🏽see patient story in Spanish here: youtu.be/N7SZ2iNfP8g #lcsm
March 31, 2025 at 2:53 PM
Best #HappyDoctorsDay 🎉gift celebrating 4 years NED scans after ChemoIO induction and pneumonectomy for locally advanced lung cancer with my patient @SylvesterCancer
👉🏽see patient story in Spanish here: youtu.be/N7SZ2iNfP8g #lcsm
👉🏽see patient story in Spanish here: youtu.be/N7SZ2iNfP8g #lcsm
The MARIPOSA effect 🦋
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25
🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25
🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm
March 27, 2025 at 2:25 AM
The MARIPOSA effect 🦋
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25
🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25
🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm
If you could make it (your argument) there, you’ll make it anywhere 🎵
Good night from Times Square New York at #GDST25 Getting ready to debate the utility of CTLA4i drugs in #lungcancer #GreatDebatesSolidTumors @SylvesterCancer
Good night from Times Square New York at #GDST25 Getting ready to debate the utility of CTLA4i drugs in #lungcancer #GreatDebatesSolidTumors @SylvesterCancer
March 22, 2025 at 12:33 PM
If you could make it (your argument) there, you’ll make it anywhere 🎵
Good night from Times Square New York at #GDST25 Getting ready to debate the utility of CTLA4i drugs in #lungcancer #GreatDebatesSolidTumors @SylvesterCancer
Good night from Times Square New York at #GDST25 Getting ready to debate the utility of CTLA4i drugs in #lungcancer #GreatDebatesSolidTumors @SylvesterCancer
🚨 A must read as more younger people get diagnosed with cancer: Updated @ASCO Guidelines on Fertility Preservation in People With Cancer: | Journal of Clinical Oncology buff.ly/BFpFrw8
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
March 22, 2025 at 12:32 PM
🚨 A must read as more younger people get diagnosed with cancer: Updated @ASCO Guidelines on Fertility Preservation in People With Cancer: | Journal of Clinical Oncology buff.ly/BFpFrw8
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
➡️ fertility preservation options for men/women/children
➡️ established and emerging methods discussed
Thrilled to speak this Thursday at the @TotalHealthConf Lung/GI #CancerUpdates
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
March 11, 2025 at 11:30 AM
Thrilled to speak this Thursday at the @TotalHealthConf Lung/GI #CancerUpdates
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
On #InternationalWomensDay, we celebrate all the contributions of #womeninmedicine .Let’s keep supporting women and give them the recognition they deserve in faculty and leadership positions. #WomenLead
March 9, 2025 at 1:23 PM
On #InternationalWomensDay, we celebrate all the contributions of #womeninmedicine .Let’s keep supporting women and give them the recognition they deserve in faculty and leadership positions. #WomenLead
We had a great time this morning @go2forlungcancer Hollywood 5K 🏃♂️ Run/ Fly Kite🪁 to raise awareness about #lungcancer and support our patients and caregivers. #lcsm @sylvestercancer
March 8, 2025 at 11:00 PM
We had a great time this morning @go2forlungcancer Hollywood 5K 🏃♂️ Run/ Fly Kite🪁 to raise awareness about #lungcancer and support our patients and caregivers. #lcsm @sylvestercancer
Join the @sylvestercancer team tomorrow for the @GO2forLungCancr 11th annual Hollywood 5K Walk/Run & Kite Fly! Supporting #lungcancer research and patient services
📆Saturday, March 8, 2025
⏰ 8AM
📍 Hollywood North Beach Park
👉🏽Support our team here: buff.ly/bj3gO3l
#lcsm
📆Saturday, March 8, 2025
⏰ 8AM
📍 Hollywood North Beach Park
👉🏽Support our team here: buff.ly/bj3gO3l
#lcsm
March 7, 2025 at 4:56 PM
Join the @sylvestercancer team tomorrow for the @GO2forLungCancr 11th annual Hollywood 5K Walk/Run & Kite Fly! Supporting #lungcancer research and patient services
📆Saturday, March 8, 2025
⏰ 8AM
📍 Hollywood North Beach Park
👉🏽Support our team here: buff.ly/bj3gO3l
#lcsm
📆Saturday, March 8, 2025
⏰ 8AM
📍 Hollywood North Beach Park
👉🏽Support our team here: buff.ly/bj3gO3l
#lcsm
🔥🔥Off the press Updated @ASCO Living Guidelines on Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations, Version 2024.3
▶️ Discussion of 2nd line options
▶️ Update on T-Dxd for HER2 IHC3+ lungcancer
▶️ No consensus on use of TTF, Dato-DXd
👉🏽 ascopubs.org/doi/10.1200/...
▶️ Discussion of 2nd line options
▶️ Update on T-Dxd for HER2 IHC3+ lungcancer
▶️ No consensus on use of TTF, Dato-DXd
👉🏽 ascopubs.org/doi/10.1200/...
March 2, 2025 at 4:43 AM
🔥🔥Off the press Updated @ASCO Living Guidelines on Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations, Version 2024.3
▶️ Discussion of 2nd line options
▶️ Update on T-Dxd for HER2 IHC3+ lungcancer
▶️ No consensus on use of TTF, Dato-DXd
👉🏽 ascopubs.org/doi/10.1200/...
▶️ Discussion of 2nd line options
▶️ Update on T-Dxd for HER2 IHC3+ lungcancer
▶️ No consensus on use of TTF, Dato-DXd
👉🏽 ascopubs.org/doi/10.1200/...
Shape the future of thoracic cancer care & nominate yourself or a colleague for an #IASLC @iaslc committee. Diverse voices drive innovation! Apply: https://bit.ly/IASLCNoms #lcsm
📅 Deadlines to nominate/accept:
👥 Colleague: 3/10/25
🙋 Self: 3/12/25
📅 Deadlines to nominate/accept:
👥 Colleague: 3/10/25
🙋 Self: 3/12/25
February 26, 2025 at 4:57 PM
Shape the future of thoracic cancer care & nominate yourself or a colleague for an #IASLC @iaslc committee. Diverse voices drive innovation! Apply: https://bit.ly/IASLCNoms #lcsm
📅 Deadlines to nominate/accept:
👥 Colleague: 3/10/25
🙋 Self: 3/12/25
📅 Deadlines to nominate/accept:
👥 Colleague: 3/10/25
🙋 Self: 3/12/25
🔥 Top 10 Most Cited JTO Articles of 2024! From groundbreaking discoveries to practice-changing research, these studies are shaping the future of thoracic oncology. Dive into the most impactful papers of the year! https://buff.ly/3CX2sE9
@JTOonline @IASLC @OncologyAdvance #LCSM
@JTOonline @IASLC @OncologyAdvance #LCSM
February 26, 2025 at 11:30 AM
🔥 Top 10 Most Cited JTO Articles of 2024! From groundbreaking discoveries to practice-changing research, these studies are shaping the future of thoracic oncology. Dive into the most impactful papers of the year! https://buff.ly/3CX2sE9
@JTOonline @IASLC @OncologyAdvance #LCSM
@JTOonline @IASLC @OncologyAdvance #LCSM
Challenging myself trainnning with a weighted vest for the @tacklecancer #DCCXV run in support of #cancerresearch @sylvestercancer. Support my team at 👉🏽: dolphinscancerchallenge.com/participant/...
February 16, 2025 at 6:43 PM
Challenging myself trainnning with a weighted vest for the @tacklecancer #DCCXV run in support of #cancerresearch @sylvestercancer. Support my team at 👉🏽: dolphinscancerchallenge.com/participant/...
👏👏👏@ASCO for promoting equitable career advancement & leadership opportunities (i.e. DEI) in new Recommendations for Academic Medical Centers-Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
February 12, 2025 at 1:43 PM
👏👏👏@ASCO for promoting equitable career advancement & leadership opportunities (i.e. DEI) in new Recommendations for Academic Medical Centers-Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
Great work by @Tony_Calles and 🇪🇸 investigators on #LUPER Ph1/2 #Lurbinectedin plus pembrolizumab in relapsed small cell lung cancer (SCLC).
N=28, no prior IO
Better OS on platinum sensitive -15.7 vs 7 mos
jto.org/article/S1556-…
N=28, no prior IO
Better OS on platinum sensitive -15.7 vs 7 mos
jto.org/article/S1556-…
February 11, 2025 at 3:52 PM
Great work by @Tony_Calles and 🇪🇸 investigators on #LUPER Ph1/2 #Lurbinectedin plus pembrolizumab in relapsed small cell lung cancer (SCLC).
N=28, no prior IO
Better OS on platinum sensitive -15.7 vs 7 mos
jto.org/article/S1556-…
N=28, no prior IO
Better OS on platinum sensitive -15.7 vs 7 mos
jto.org/article/S1556-…